Today, COVID-19 booster shots are now eligible to everyone in the U.S ages 18 years old and above. The Centers for Disease Control and Prevention (CDC) Director Rochelle P. Wilensky, M.D., M.P.H., strongly recommend and endorse it to the CDC Advisory Committee on Immunization Practices (ACIP).
Pfizer-BioNTech or Moderna COVID-19 vaccine
On Friday, with immediate effect, those individuals who received their second shots from Pfizer or Moderna with 6 months or more COVID-19 vaccine are all eligible to take the booster shot.
On the other hand, with estimated 15 million people who got the Johnson & Johnson ages 18 years old above who were vaccinated two or more months ago are qualified for the booster to get more additional protection against COVID-19.
The Food and Drug Administration’s (FDA) and U.S. Centers for Disease Control and Prevention (CDC) authorized and take action for expanding the booster for COVID-19 shots to all adults.
The regulatory reviews are now handled by Director Wilensky and with her full support with this matter she also stated that “As CDC Director, it is my job to recognize where our actions can have the greatest impact,” she added “At CDC, we are tasked with analyzing complex, often imperfect data to make concrete recommendations that optimize health. In a pandemic, even with uncertainty, we must take actions that we anticipate will do the greatest good.”
Moreover, Biden’s administration officials have been encouraging every eligible adult to get the booster as soon as possible.
Andy Slavitt, a Senior White House pandemic advisor said that “Things are about to get a whole lot easier,” because all 50 states in America with individuals age 16 years old above are all eligible for the COVID-19 vaccine. Meanwhile, the unvaccinated still remains the top priority.
The primary vaccination of COVID-19 continues to circulate in America to provide strong protection and avoid severe disease and worst death. COVID-19 still runs across the country and studies show that the booster is a big help to increase antibody levels that could reduce the spread and get easily infected with the virus.